Histological analysis via HE staining revealed reduced tumor burden, while IHC analysis demonstrated significantly lower expression levels of tumor biomarkers CK‐19 and Ki67 in liver samples from the NAT10 knockdown group (Figure 3J–M). The gene discussed is NAT10; the disease is neoplasm.